Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.
Who will be affected?
Readers: No access to all 28 journals. We recommend accessing our articles via PubMed Central
Authors: No access to the submission form or your user account.
Reviewers: No access to your user account. Please download manuscripts you are reviewing for offline reading before Wednesday, July 01, 2020 at 7:00 PM.
Editors: No access to your user account to assign reviewers or make decisions.
Copyeditors: No access to user account. Please download manuscripts you are copyediting before Wednesday, July 01, 2020 at 7:00 PM.
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
The challenges of COVID-19 for people living with diabetes: how can digital health help?
Anissa Gamble;
Quynh Pham;
Shivani Goyal;
Joseph A Cafazzo
ABSTRACT
We prepared this commentary to explore how the field of digital health can help address gaps and burdens within the diabetes community during the COVID-19 pandemic. Diabetes affects the severity of COVID-19 infection due to glycemic control, medication pharmacodynamics, social distancing effects, and insulin access. Digital health may improve diabetes health outcomes through enabling remote care in place of in-person visits. We conclude that COVID-19 may usher a digital health paradigm shift and accelerate the routine clinical application of digital diabetes tools, but will require that solutions be effectively supported and implemented.
Citation
Please cite as:
Gamble A, Pham Q, Goyal S, Cafazzo JA
The Challenges of COVID-19 for People Living With Diabetes: Considerations for Digital Health